185 related articles for article (PubMed ID: 9660462)
1. Lytic antibodies in Trypanosoma cruzi-infected persons with low parasitemia.
Zulantay I; Venegas J; Apt W; Solari A; Sanchez G
Am J Trop Med Hyg; 1998 Jun; 58(6):775-9. PubMed ID: 9660462
[TBL] [Abstract][Full Text] [Related]
2. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
Wallace A; Sanchez G; Venegas J; Solari A
Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
[TBL] [Abstract][Full Text] [Related]
4. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens.
Sánchez B; Monteón V; Reyes PA; Espinoza B
Arch Med Res; 2001; 32(5):382-8. PubMed ID: 11578752
[TBL] [Abstract][Full Text] [Related]
5. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
6. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli.
O'Daly JA; Carrasco H; Fernandez V; Rodríguez MB
Acta Trop; 1994 Apr; 56(4):265-87. PubMed ID: 8023751
[TBL] [Abstract][Full Text] [Related]
7. Use of Tc-rCRP as a target for lytic antibody titration after experimental Trypanosoma cruzi infection.
Marques T; Silva GC; Henrique Paiva PM; Nascentes GAN; Ramirez LE; Norris K; Meira WSF
Exp Parasitol; 2018 Jan; 184():103-108. PubMed ID: 29246832
[TBL] [Abstract][Full Text] [Related]
8. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
[TBL] [Abstract][Full Text] [Related]
9. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
Almeida IC; Krautz GM; Krettli AU; Travassos LR
J Clin Lab Anal; 1993; 7(6):307-16. PubMed ID: 8277354
[TBL] [Abstract][Full Text] [Related]
10. Antibody maturation in Trypanosoma cruzi-infected rats.
Marcipar IS; Risso MG; Silber AM; Revelli S; Marcipar AJ
Clin Diagn Lab Immunol; 2001 Jul; 8(4):802-5. PubMed ID: 11427430
[TBL] [Abstract][Full Text] [Related]
11. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
Umekita LF; Ramos DP; Barbaro KC; Mota I
Immunol Lett; 1999 Nov; 70(2):73-6. PubMed ID: 10569694
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to human heart conduction system in Chagas' disease.
Arce-Fonseca M; Ballinas-Verdugo MA; Reyes PA; Aranda-Fraustro A; Monteón VM
Vector Borne Zoonotic Dis; 2005; 5(3):233-6. PubMed ID: 16187891
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
[TBL] [Abstract][Full Text] [Related]
14. Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.
Krautz GM; Galvão LM; Cançado JR; Guevara-Espinoza A; Ouaissi A; Krettli AU
J Clin Microbiol; 1995 Aug; 33(8):2086-90. PubMed ID: 7559953
[TBL] [Abstract][Full Text] [Related]
15. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.
Yoshida N
Exp Parasitol; 1986 Apr; 61(2):184-91. PubMed ID: 3082663
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection.
Avila JL; Rojas M; Velazquez-Avila G
Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994
[TBL] [Abstract][Full Text] [Related]
18. Chagas' disease: polyspecificity of antibodies against Trypanosoma cruzi acidic antigens.
Ordoñez P; Gea S; Iosa D; Vottero-Cima E
Acta Trop; 1995 May; 59(2):93-103. PubMed ID: 7676911
[TBL] [Abstract][Full Text] [Related]
19. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.
Gea S; Ordonez P; Cerban F; Iosa D; Chizzolini C; Vottero-Cima E
Am J Trop Med Hyg; 1993 Nov; 49(5):581-8. PubMed ID: 7504407
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi strains in the Calomys callosus: parasitemia and reaction of intracellular forms with stage-specific antibodies in the acute and chronic phase of infection and after immunosuppression.
Taniwaki NN; Gonçalves VM; Romero JK; da Silva CV; da Silva S; Mortara RA
Parasitol Res; 2011 Aug; 109(2):431-40. PubMed ID: 21331788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
